Streetbeat News

Stock Prices

ZVSA

ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) shares surged after announcing the publication of a scientific paper in 'Frontiers in Molecular Neuroscience'. The paper, authored by researchers from the University of Miami Miller School of Medicine, supports the use of ZyVersa's IC 100 to potentially reduce cardiac issues in Alzheimer's patients by inhibiting ASC inflammasomes. Additionally, ZyVersa executed a 1-for-20 reverse stock split last Friday, resulting in a float of less than 758,000 shares. The company does not pay dividends but engages in other capital allocation strategies.

Portfolio Pulse from Erica Kollmann

April 29, 2024 | 2:53 pm

ANVS

Annovis Bio's shares were halted due to a circuit breaker triggered by a significant drop, with the stock currently down 48.1%.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 2:52 pm

DCPH

HTLF

TSLA

Stocks like Tesla, Deciphera Pharmaceuticals, and Heartland Financial saw significant movements. Tesla partnered with Baidu for Full Self-Driving in China, causing a 10.5% jump. Deciphera Pharmaceuticals surged 73% after an acquisition announcement by ONO Pharmaceutical. Heartland Financial rose 17.2% following UMB Financial's acquisition announcement. Other stocks also recorded gains due to various positive developments, including FDA approvals, financial settlements, and analyst upgrades.

Portfolio Pulse from Avi Kapoor

April 29, 2024 | 2:47 pm

ANVS

Annovis Bio's stock was halted due to a circuit breaker after experiencing a significant drop of 37.8%. This drastic decrease in stock price indicates a substantial market reaction, potentially due to negative news or disappointing financial results from the company.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 2:46 pm

ANVS

Trading of Annovis Bio shares has resumed, indicating a potential shift in market dynamics for the company.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 2:46 pm

ANVS

Annovis Bio's shares were halted due to a circuit breaker triggered by a significant drop, with the stock now down 25.6%.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 2:45 pm

A

Agilent Technologies (NYSE:A) has seen a 10.14% increase in its short percent of float since the last report, with 3.95 million shares sold short, representing 1.52% of available shares. This increase in short interest indicates a more bearish market sentiment towards the company, although it has less short interest compared to its peers' average of 5.20%. The article suggests that while an increase in short interest can signal bearish sentiment, it can also be bullish under certain conditions.

Portfolio Pulse from Benzinga Insights

April 29, 2024 | 2:45 pm

NNN

NNN REIT (NYSE:NNN) has seen a decrease in short interest, now at 2.66% of its float, lower than the peer group average of 5.31%. This reduction from 3.54 million shares suggests a more bullish sentiment among investors. The coverage time for short positions is approximately 3.01 days based on current trading volumes.

Portfolio Pulse from Benzinga Insights

April 29, 2024 | 2:45 pm

MRNS

Marinus Pharma's (NYSE:MRNS) short interest has decreased by 3.64%, now representing 6.35% of its float with 3.47 million shares sold short. This decline in short interest could indicate a more bullish sentiment towards MRNS among traders. The current short interest still exceeds the peer group average of 3.91%, suggesting a higher level of bearishness compared to its peers. Short interest is a critical market sentiment indicator, and changes can influence stock price movements.

Portfolio Pulse from Benzinga Insights

April 29, 2024 | 2:45 pm

ANVS

Annovis Bio shares were halted due to a circuit breaker triggered by a 14.7% drop in stock price.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 2:36 pm